These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


472 related items for PubMed ID: 16329645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immune regulation in psoriasis and psoriatic arthritis--recent developments.
    Hueber AJ, McInnes IB.
    Immunol Lett; 2007 Dec 15; 114(2):59-65. PubMed ID: 17928070
    [Abstract] [Full Text] [Related]

  • 3. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
    Goedkoop AY, Kraan MC, Teunissen MB, Picavet DI, de Rie MA, Bos JD, Tak PP.
    Ann Rheum Dis; 2004 Jul 15; 63(7):769-73. PubMed ID: 15194570
    [Abstract] [Full Text] [Related]

  • 4. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
    Bevelacqua V, Libra M, Mazzarino MC, Gangemi P, Nicotra G, Curatolo S, Massimino D, Plumari A, Merito P, Valente G, Stivala F, La Greca S, Malaponte G.
    Int J Mol Med; 2006 Sep 15; 18(3):415-23. PubMed ID: 16865225
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Three decades of psoriasis research: where has it led us?
    Sabat R, Sterry W, Philipp S, Wolk K.
    Clin Dermatol; 2007 Sep 15; 25(6):504-9. PubMed ID: 18021885
    [Abstract] [Full Text] [Related]

  • 9. Cytokines and anticytokines in psoriasis.
    Pietrzak AT, Zalewska A, Chodorowska G, Krasowska D, Michalak-Stoma A, Nockowski P, Osemlak P, Paszkowski T, Roliński JM.
    Clin Chim Acta; 2008 Aug 15; 394(1-2):7-21. PubMed ID: 18445484
    [Abstract] [Full Text] [Related]

  • 10. New biologics for psoriasis and psoriatic arthritis.
    Rozenblit M, Lebwohl M.
    Dermatol Ther; 2009 Aug 15; 22(1):56-60. PubMed ID: 19222517
    [Abstract] [Full Text] [Related]

  • 11. Immunopathogenesis of psoriasis and pharmacological perspectives.
    Loffredo S, Ayala F, Marone G, Delfino G, Stranges S, Marone G.
    J Rheumatol Suppl; 2009 Aug 15; 83():9-11. PubMed ID: 19661527
    [Abstract] [Full Text] [Related]

  • 12. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C, Nasorri F, Girolomoni G, Pità Od, Cavani A.
    Br J Dermatol; 2007 Aug 15; 157(2):249-58. PubMed ID: 17489975
    [Abstract] [Full Text] [Related]

  • 13. Psoriatic disease--from skin to bone.
    Ritchlin C.
    Nat Clin Pract Rheumatol; 2007 Dec 15; 3(12):698-706. PubMed ID: 18037929
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases.
    McInnes IB, Gracie JA.
    Curr Opin Pharmacol; 2004 Aug 15; 4(4):392-7. PubMed ID: 15251134
    [Abstract] [Full Text] [Related]

  • 15. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
    Andersson AK, Feldmann M, Brennan FM.
    Scand J Immunol; 2008 Jul 15; 68(1):103-11. PubMed ID: 18482208
    [Abstract] [Full Text] [Related]

  • 16. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
    Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D.
    Arthritis Rheum; 2009 Apr 15; 60(4):966-75. PubMed ID: 19333931
    [Abstract] [Full Text] [Related]

  • 17. Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives.
    Loffredo S, Ayala F, Marone GC, Genovese A, Marone G.
    Reumatismo; 2007 Apr 15; 59 Suppl 1():28-39. PubMed ID: 17828356
    [Abstract] [Full Text] [Related]

  • 18. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A, Kanno H, Watabe D, Akasaka T, Sawai T.
    Arch Dermatol Res; 2008 Jan 15; 300(1):37-45. PubMed ID: 17960400
    [Abstract] [Full Text] [Related]

  • 19. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
    Williams RO, Paleolog E, Feldmann M.
    Curr Opin Pharmacol; 2007 Aug 15; 7(4):412-7. PubMed ID: 17627887
    [Abstract] [Full Text] [Related]

  • 20. Chronic inflammation in psoriasis and obesity: implications for therapy.
    Hamminga EA, van der Lely AJ, Neumann HA, Thio HB.
    Med Hypotheses; 2006 Aug 15; 67(4):768-73. PubMed ID: 16781085
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.